Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.

Authors: lionetti R

Date: May 2019

Scope of interest: infectious/hepatological

You may also be interested in:

Report/Poster of Convention/Congress Act

Continuous partial epilepsy following a febrile state at spontaneous resolution

Authors: A. Morano, J. Fattouch, S. Casciato, L. Lapenta, M. Fanella, M. Albini, A.T. Giallonardo, C. Di Bonaventura

Date: 2014

Scope of interest: Epilepsy

Read details

Report/Poster of Convention/Congress Act

Non-pharmacological therapy in the treatment of Dementia

Authors: Abatecola Angela Marie

Date: 2021

Scope of interest: Alzheimer's

Read details

Report/Poster of Convention/Congress Act

– Outpatient management of anaemia secondary to epistaxis in patients with Rendu-Osler disease: the role of intravenous martial therapy

Authors: Maria Trimboli(1) - Federico De Angelis (1) - Francesca Docimo (1) - Elena Gigliotti(1) - Giorgia Guiducci(1) - Paolo Paesano (1) - Ida Provenzano (1) - Cristina D'Amico (1) - Simona Fornella (1) - Sonia Romoli(1) - Augusto Di Folco (1) - Carla Gargiulo (

Date: 2022

Scope of interest: Clinical pathology

Read details